The prevalence of colonization with vancomycin-resistant Enterococcus at a veterans' affairs institution

被引:49
作者
Tokars, JI
Satake, S
Rimland, D
Carson, L
Miller, ER
Killum, E
Sinkowitz-Cochran, RL
Arduino, MJ
Tenover, FC
Marston, B
Jarvis, WR
机构
[1] Ctr Dis Control & Prevent, Hosp Infect Program, Atlanta, GA 30333 USA
[2] Vet Affairs Med Ctr, Med Serv, Atlanta, GA USA
关键词
D O I
10.1086/501606
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVE: To study vancomycin-resistant Enterococcus (VRE) prevalence, risk factors, and clustering among hospital inpatients. DESIGN: Rectal-swab prevalence culture survey conducted from February 5 to March 22, 1996. SETTING: The Veterans' Affairs Medical Center, Atlanta, Georgia. PATIENTS: Hospital (medical and surgical) inpatients. RESULTS: The overall VRE prevalence was 29% (42/147 patients). The VRE prevalence was 52% (38/73 patients) among patients who had received at least one of six specific antimicrobials during the preceding 120 days, compared with only 5% (4/74) among those who had not received the antimicrobials (relative risk, 9.6; P<.001). The longer the period (up to 120 days) during which antimicrobial use was studied, the more closely VRE status was predicted. Among 67 hospital patients in 28 multibed rooms, clustering of VRE among current roommates was not found. CONCLUSIONS: At this hospital with relatively high VRE prevalence, VRE: colonization was related to antibiotic use but not to roommate VRE, status. In hospitals with a similar VRE epidemiology, obtaining cultures from roommates of VRE-positive patients may not be as efficient a strategy for identifying VRE-colonized patients as obtaining screening cultures from patients who have received antimicrobials.
引用
收藏
页码:171 / 175
页数:5
相关论文
共 21 条
[1]  
ANGLIM A, 1996, INFECT CONTROL HOS S, V17, pP18
[2]  
[Anonymous], 1995, MMWR Recomm Rep, V44, P1
[3]  
ARMITAGE P, 1987, STAT METHODS MED RES, P56
[4]  
Bonilla HF, 1997, INFECT CONT HOSP EP, V18, P333, DOI 10.1086/647621
[5]  
BOYCE JM, 1995, INFECT CONT HOSP EP, V16, P634
[6]   OUTBREAK OF MULTIDRUG-RESISTANT ENTEROCOCCUS-FAECIUM WITH TRANSFERABLE VANB CLASS VANCOMYCIN RESISTANCE [J].
BOYCE, JM ;
OPAL, SM ;
CHOW, JW ;
ZERVOS, MJ ;
POTTERBYNOE, G ;
SHERMAN, CB ;
ROMULO, RLC ;
FORTNA, S ;
MEDEIROS, AA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (05) :1148-1153
[7]   VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECIUM BACTEREMIA - RISK-FACTORS FOR INFECTION [J].
EDMOND, MB ;
OBER, JF ;
WEINBAUM, DL ;
PFALLER, MA ;
HWANG, T ;
SANFORD, MD ;
WENZEL, RP .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (05) :1126-1133
[8]  
KARANFIL LV, 1992, INFECT CONT HOSP EP, V13, P195, DOI 10.1086/646509
[9]   Severity of illness scoring systems to adjust nosocomial infection rates: A review and commentary [J].
KeitaPerse, O ;
Gaynes, RP .
AMERICAN JOURNAL OF INFECTION CONTROL, 1996, 24 (06) :429-434
[10]   APACHE-II - A SEVERITY OF DISEASE CLASSIFICATION-SYSTEM [J].
KNAUS, WA ;
DRAPER, EA ;
WAGNER, DP ;
ZIMMERMAN, JE .
CRITICAL CARE MEDICINE, 1985, 13 (10) :818-829